Litcius/Paper detail

Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery

Man Kyu Shim, Suah Yang, In‐Cheol Sun, Kwangmeyung Kim

2022Advanced Drug Delivery Reviews152 citationsDOI

Topics & Concepts

ProdrugTumor microenvironmentImmunotherapyDrug deliveryImmune systemMedicineCancer researchDrugImmunogenicityCancer immunotherapyNanomedicinePharmacologyImmunologyNanotechnologyMaterials scienceNanoparticleNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryImmunotherapy and Immune Responses
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery | Litcius